
Boryung CEO charts bold future with space healthcare vision, reinforces pharma core
Boryung, which surpassed 1 trillion won ($679.8 million) in annual revenue last year, has reaffirmed its commitment to strengthening its core pharmaceutical business while aggressively investing in space medicine as a strategic growth engine. At its 61st …